Scream your way to happiness? Maybe not, but scream clubs promise some relief

medicalxpress - With a gut-wrenching wail that rippled from her body, Amber Walcker joined about a dozen screaming people in West Seattle who let their frustrations float away over the Puget Sound.

AI Summary: Scream clubs tout catharsis and quick emotional relief, but evidence for lasting mental‑health benefits is sparse. Research suggests short‑lived mood boosts largely driven by social bonding and novelty rather than durable therapeutic change. In short: yelling at strangers might feel good for a night, but don’t expect it to replace therapy.

Nadia Care raises $12M to grow Medicaid maternal care

Ngai Yeung / endpoints - A maternal care startup offering virtual and in-person care just raised $12 million in new funding after dropping commercial insurers to focus on Medicaid, Endpoints News learned exclusively. Nadia Care, previously known as Cayaba Care ...

AI Summary: Nadia Care secured $12 million to expand its community‑centered maternal care model, increasing Medicaid‑focused doula and perinatal support services. The funding aims to scale access in underserved areas, bolster nonclinical supports that improve outcomes, and reduce maternal health disparities — because apparently traditional care alone wasn't cutting it.

TerraPower Isotopes Invests $450M in Actinium-225 Production Facility

oncodaily - TerraPower Isotopes (TPI), the Bill Gates-founded nuclear science company, unveiled plans on March 17, 2026 to invest $450 million in a state-of-the-art actinium-225 (Ac-225) manufacturing facility in Philadelphia’s Bellwether District. The 250,000-square…

AI Summary: TerraPower announced a $450 million investment to construct a commercial Actinium‑225 production facility to supply alpha‑emitting radioisotopes for targeted cancer therapies. The plan tackles chronic supply shortages, strengthens domestic radiopharmaceutical capacity and positions the company at the center of growing demand for targeted‑alpha therapeutics — and yes, investors are watching.

This common vaccine cuts heart risk nearly in half in new study

sciencedaily - A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications …

AI Summary: New research finds that receipt of a common shingles vaccine is associated with roughly a 50% reduction in serious cardiac events in the studied population. Investigators propose immune‑modulating mechanisms may underlie the protective effect; if confirmed, the vaccine could offer a tidy twofer—preventing shingles and cutting heart risk—proof that prevention sometimes moonlights as cardiology.

A liquid biopsy blood test may improve children's survival of cancer in Africa

medicalxpress - In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a minimally invasive liquid biopsy test can diagnose Burkitt l…

AI Summary: A blood‑based liquid biopsy for EBV‑positive Burkitt’s lymphoma shows promise for earlier, less invasive diagnosis in endemic regions, potentially improving pediatric survival where tissue biopsies are scarce. Early data indicate actionable sensitivity and feasibility for low‑resource settings, offering a scalable path to faster treatment.

What happens to your brain in nature? The neuroscience explained

medicalxpress - Have you ever felt calmer almost as soon as you step into the woods? Or maybe noticed your busy mind soften as you look out at the sea?

AI Summary: Researchers report that immersive time in natural settings produces detectable changes in brain networks tied to attention, emotion regulation and memory. The findings suggest brief nature exposure can recalibrate neural states and boost mental health — science’s polite way of telling you to go outside instead of doomscrolling.

Verily raises $300M, sheds Alphabet’s majority control

Shelby Livingston / endpoints - Verily has raised $300 million in new, outside funding that ends parent company Alphabet's controlling position in the healthcare innovation company, Endpoints News has learned exclusively. The funding round was led by Series X Capital ...

AI Summary: Verily secured a $300 million financing round that reduces Alphabet’s majority control, bringing new strategic investors on board including health system partners. The cash infusion aims to accelerate Verily’s healthcare technology and platform ambitions — because nothing says “healthcare disruption” like another well‑funded pivot.

Engineered tissue offers hope for children born with 'missing' esophagus

medicalxpress - Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus—the food pipe—shown to safely replace a full section of the organ and restore normal function, including swallowing, in a gr…

AI Summary: Researchers report progress developing lab-grown esophageal tissue to treat children born with congenital absence or severe damage of the esophagus. Early preclinical and surgical work demonstrates that engineered tissue constructs can be implanted and integrated, offering a potential alternative to complex reconstructions — a promising step for tiny patients with very big problems.

Turquoise Health Snags $40M to Simplify Healthcare Contracts & Payments

Katie Adams / medcitynews - Turquoise Health raised $40 million in a Series C round to expand beyond price transparency into managing healthcare contracts. The startup’s platform aims to simplify payer–provider agreements, reduce administrative waste and enable patients to see guara…

AI Summary: Turquoise Health closed a $40 million funding round to accelerate its platform that standardizes healthcare contracts and payments, aiming to increase price transparency and streamline payer–provider interactions. The cash infusion will support product growth, sales expansion and the company's push to make messy contract data slightly less catastrophic for hospital finance teams.

Rob Winn Appointed Director of NCI-Designated Fox Chase Cancer Center

oncodaily - Fox Chase Cancer Center shared a post on LinkedIn: “Temple Health – Temple University Health System today announced the appointment of Dr. Rob Winn, MD, as the next Cancer Center […]

AI Summary: Rob Winn has been appointed director of the NCI‑designated Fox Chase Cancer Center, taking the reins of clinical, research and strategic operations. His role will focus on strengthening translational research, patient care integration and institutional partnerships to advance the center's mission — you know, the usual: cure more cancer, argue less in committee meetings.